Monoclonal Anti-CD47 Therapy and its Haematological Effects, including Anaemia and Thrombocytopenia
Monoclonal anti-CD47 therapy is a new form of immunotherapy, which has been used in a clinical setting in recent years for the treatment of haematological and solid malignancies. Anti-CD47 functions by blocking the CD47-SIRPα interaction and promotes the phagocytosis of cancer cells, which attempt to invade the immune systems mechanisms via this interface.
Publication Details
- Journal
- Emergency Medicine Trauma & Surgical Care
- Published
- 2024-08-30
- DOI
- https://doi.org/10.24966/ets-8798/100070
- Primary Topic
- Phagocytosis and Immune Regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00